Obstetric Care Consensus. Number 10. March 2020
Вперше опубліковано Practice Bulletin № 102, березень 2009

Цей документ було розроблену разом із Американським Коледжем акушерства і гінекології та Товариством медицини матері та плоду зі співробітництвом Torri D. Metz, MD, MS; Rana Snipe Berry, MD; Ruth C. Fretts, MD; Uma M. Reddy, MD, MPH; and Mark A. Turrentine, MD.

ЛІТЕРАТУРА

1. Health Canada. Special report on maternal mortality and severe morbidity in Canada. Enhanced surveillance: the path to prevention. Ottawa: Minister of Public Works and Government Services Canada; 2004.

2. Centre for Maternal and Child Enquiries. Saving mothers' lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011; 118(Suppl 1):1–203.

3. Magee LA, Pels A, Helewa M, Rey E, Von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014. Available at: http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext. Accessed on February 28, 2014.

4. Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardio Clin 2010; 28:571–86.

5. Redman CWG. The placenta, pre-eclampsia and chronic villitis. In: Redman CWG, Sargent IL SP, eds. The human placenta. Oxford: Blackwell Scientific; 1993:433–67.

6. von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, et al.; PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377(9761):219–27.

7. Payne B, Magee LA, Menzies J, Cote AM, Hutcheon JA, Kyle P, et al.; PIERS Study Group. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecol Can 2011;33:588–97.

8. Lampinen KH, Ronnback M, Groop PH, Kaaja RJ. Renal and vascular function in women with previous preeclampsia: a comparison of low and high-degree proteinuria. Kidney Int 2006;70:1818–22.

9. Gruslin A, Lemyre B. Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clinl Obstet Gynaecol 2011;25:401–507.

10. Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Data-base Syst Rev. 2008 Jan 23;(1):CD000038.

11. Kaur S, Picconi JL, Chadha R, Kruger M, Mari G. Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000 g. Am J Obstet Gynecol 2008;199:264.e1–4.

12. Payne BA, Kyle PM, Lim K, Lisonkova S, Magee LA, Pullar B, et al. An assessment of predictive value of the biophysical profile in women with preeclampsia using data from the full PIERS database. Pregnancy Hypertens 2013;3:166–71.

13. Urquia ML, Ying I, Glazier RH, Berger H, De Souza LR, Ray JG. Serious preeclampsia among different immigrant groups. J Obstet Gynaecol Can 2012;34:348–52.

14. Magee LA, Helewa M, Moutquin JM, von Dadelszen P; Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. SOGC Clinical Practice Guidelines, No. 206, March 2008. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30(3 Suppl 1):S1-S48.

15. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122—31.

16. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20(1):IX–XIV.

17. Why mothers die 2000–2002. The sixth report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004.

18. Rey E, Morin F, Boudreault J, Pilon F, Vincent D, Ouellet D. Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient- or nurse-measured blood pressure. Hypertens Pregnancy 2009;28:168–77.

19. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG 2005;112:601–6.

20. Magee LA, Ramsay G, von Dadelszen P. What is the role of out-of-office BP measurement in hypertensive pregnancy? Hypertens Pregnancy 2008;27:95–101.

21. Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998;105:1177–84.

22. Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG 2005;112:915–20.

23. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004;85 (Suppl 1):S28-S41.

24. Bellomo G, Narducci PL, Rondoni F, Pastorelli G, Stangoni G, Angeli G, et al. Prognostic value of 24-hour blood pressure in pregnancy. JAMA 1999;282:1447–52.

25. Hermida RC, Ayala DE, Iglesias M. Circadian rhythm of blood pressure challenges office values as the «gold standard» in the diagnosis of gestational hypertension. Chronobiol Int 2003;20:135–56.

26. Eguchi, Kazuo O, Akihide O, Takako H, Chikako T, Kayo S, et al. [abstracts of American Society of Hypertension 27th Annual Scientific Meeting and Exposition]. J Clin Hypertens 2012;14(Suppl 1):doi: 10.1111/j.1751-7176.2011.00665.x.

27. Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol 2007;109:956–66.

28. Fesenmeier MF, Coppage KH, Lambers DS, Barton JR, Sibai BM. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 2005;192:1416–9.

29. Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 2010;10:74–9.

30. Martin JN Jr, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955–2006. Am J Obstet Gynecol 2008;199:98–104.

31. Mouthon L, Berezne A, Bussone G, Noel LH, Villiger PM, Guillevin L. Scleroderma renal crisis: a rare but severe complication of systemic sclerosis. Clin Rev Allergy Immunol 2011;40:84–91.

32. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011;39:641–52. doi: 10.1515/JPM.2011.098.

33. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8–15.

34. Scazzocchio E, Figueras F, Crispi F, Meler E, Masoller N, Mula R, et al. Performance of a first-trimester screening of pre-eclampsia in a routine care low-risk setting. Am J Obstet Gynecol 2013;208(3):203.e1-203.e10.

35. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006;(3)CD004454.

36. Stutchfield P, Whitaker R, Russell I; Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ 2005;331:662.

37. Roberts D; Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. Green-top Guideline No. 7. London: Royal College of Obstetricians and Gynaecologists; 2010. Available at: http://www.rcog.org.uk/files/rcog-corp/GTG%207.pdf. Accessed on February 28, 2014.

38. Shennan AH, Redman C, Cooper C, Milne F. Are most maternal deaths from pre-eclampsia avoidable? Lancet 2012;379(9827):1686–7.

39. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207–8.